Carlyle Group Inc., a registered investment adviser, initiated a new position in Medline Inc. (NASDAQ GLOBAL SELECT:MDLN) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 215,303,036 shares of the company, valued at approximately $9.0B as of the filing date.
Medline Inc.'s stock currently trades at $44.55.